Bridgewater Associates increased its Eli Lilly share position, while ARK Invest held a significant stake in Eli Lilly and added to its Nvidia holdings.

The entities involved

• Eli Lilly and Company →

  American pharmaceutical company

  • ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
  • The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59
• Bridgewater Associates →

  asset manager

  • Patrick Gorman's professional profile includes roles as EVP at Booz Allen Hamilton, CSO at Bridgewater Associates, and his academic background from George Washington University.Thu 10:15
• Ark Invest →

  American asset management firm

  • ARK Invest is focusing its investments on consumer crypto brokerages, digital asset infrastructure, and stablecoin issuers.Thu 19:29
  • Ark Invest is tokenizing its fund using Securitize infrastructure and making ARKVX available on the Ethereum network.Thu 19:29
• Nvidia →

  American multinational technology company

  • Apple is utilizing TSMC for advanced chip manufacturing, a trend observed alongside market pricing pressures affecting sales volume.Mon 17:45
  • A market sell-off hit major chip companies (AMD, Intel, Micron, Samsung, Nvidia) as the AI trade cooled and investors entered risk-off mode.Mon 17:34

Related events

• Bridgewater Associates, founded by Ray Dalio, announced major portfolio shifts on August 18, 2026, reducing its stake in Nvidia while significantly increasing its holdings in Shell.Aug 18
• Nvidia, Eli Lilly, and Booking Holdings are high-growth stocks attracting investor attention, with Eli Lilly being specifically compared to Booking Holdings' stock split.Sep 5
• Bridgewater Associates made significant investment moves regarding Nvidia and Vistra, and invested in a digital infrastructure venture with Vistra.Sep 3
• Ark Invest made multiple trades on August 14, 2026, including investments in TSMC, Nvidia, and SpaceX, and trimming Amazon and Shopify holdings.Aug 15
• Morgan Stanley increased its stake in Eli Lilly stock, and the company filed required reports with the SEC.Jul 9